Lista de obras -

Anti-HIV-1 antibody-dependent cellular cytotoxicity mediated by hyperimmune bovine colostrum IgG.

artículo científico publicado en 2012

Antibody-dependent effector functions against HIV decline in subjects receiving antiretroviral therapy

artículo científico publicado en 2014

Application of a case-control study design to investigate genotypic signatures of HIV-1 transmission

artículo científico publicado en 2012

Balancing reversion of cytotoxic T-lymphocyte and neutralizing antibody escape mutations within human immunodeficiency virus type 1 Env upon transmission

scientific article published on 10 June 2009

Breadth of HIV-1 Env-specific antibody-dependent cellular cytotoxicity: relevance to global HIV vaccine design

artículo científico publicado en 2014

Brief Report: Seminal Plasma Anti-HIV Antibodies Trigger Antibody-dependent Cellular Cytotoxicity: Implications for HIV Transmission

artículo científico publicado en 2016

Co-expression of miRNA targeting the expression of PERK, but not PKR, enhances cellular immunity from an HIV-1 Env DNA vaccine

artículo científico publicado en 2011

Conjugation of an scFab domain to the oligomeric HIV envelope protein for use in immune targeting

artículo científico publicado en 2019

Differentiating founder and chronic HIV envelope sequences.

artículo científico publicado en 2017

Disulfide bond that constrains the HIV-1 gp120 V3 domain is cleaved by thioredoxin

artículo científico publicado en 2010

Efficient transcription through an intron requires the binding of an Sm-type U1 snRNP with intact stem loop II to the splice donor

artículo científico publicado en 2010

Enhancing the antigenicity and immunogenicity of monomeric forms of hepatitis C virus E2 for use as a preventive vaccine

artículo científico publicado en 2020

HIV-1 Env- and Vpu-Specific Antibody-Dependent Cellular Cytotoxicity Responses Associated with Elite Control of HIV.

artículo científico

HIV-1-based Virus-like Particles that Morphologically Resemble Mature, Infectious HIV-1 Virions

scientific article published on 02 June 2019

Hyperimmune bovine colostrum as a low-cost, large-scale source of antibodies with broad neutralizing activity for HIV-1 envelope with potential use in microbicides.

artículo científico publicado en 2012

Immune escape from HIV-specific antibody-dependent cellular cytotoxicity (ADCC) pressure

artículo científico publicado en 2011

Induction of HIV-1 subtype B and AE-specific neutralizing antibodies in mice and macaques with DNA prime and recombinant gp140 protein boost regimens.

artículo científico publicado en 2009

Inhibition of two temporal phases of HIV-1 transfer from primary Langerhans cells to T cells: the role of langerin

artículo científico publicado en 2014

Isotype-switched immunoglobulin G antibodies to HIV Gag proteins may provide alternative or additional immune responses to ‘protective’ human leukocyte antigen-B alleles in HIV controllers

article

Memory B Cells, the HLA-B*57 Allele and Natural Control of HIV Infection

artículo científico publicado en 2017

NK cell function and antibodies mediating ADCC in HIV-1-infected viremic and controller patients

artículo científico publicado en 2011

Oligomeric structure of the human immunodeficiency virus type 1 envelope protein on the virion surface

artículo científico publicado en 2002

Partial efficacy of a broadly neutralizing antibody against cell-associated SHIV infection

artículo científico publicado en 2017

Promoting trimerization of soluble human immunodeficiency virus type 1 (HIV-1) Env through the use of HIV-1/simian immunodeficiency virus chimeras

artículo científico publicado en 2004

Rapid degranulation of NK cells following activation by HIV-specific antibodies.

artículo científico publicado en 2009

Repeated Vaccination of Cows with HIV Env gp140 during Subsequent Pregnancies Elicits and Sustains an Enduring Strong Env-Binding and Neutralising Antibody Response

artículo científico publicado en 2016

Role of education and differentiation in determining the potential of natural killer cells to respond to antibody-dependent stimulation.

artículo científico publicado en 2014

Sindbis virus vectors elicit hemagglutinin-specific humoral and cellular immune responses and offer a dose-sparing strategy for vaccination

artículo científico publicado en 2008

The core domain of hepatitis C virus glycoprotein E2 generates potent cross-neutralizing antibodies in guinea pigs

artículo científico publicado en 2016

The maturation of antibody technology for the HIV epidemic

artículo científico

Trimeric gp120-specific bovine monoclonal antibodies require cysteine and aromatic residues in CDRH3 for high affinity binding to HIV Env.

artículo científico publicado en 2016

Utility of the Sindbis replicon system as an Env-targeted HIV vaccine.

artículo científico publicado en 2013

Lista de obras de

Anti-HIV-1 antibody-dependent cellular cytotoxicity mediated by hyperimmune bovine colostrum IgG.

Antibody-dependent effector functions against HIV decline in subjects receiving antiretroviral therapy

Application of a case-control study design to investigate genotypic signatures of HIV-1 transmission

Balancing reversion of cytotoxic T-lymphocyte and neutralizing antibody escape mutations within human immunodeficiency virus type 1 Env upon transmission

Breadth of HIV-1 Env-specific antibody-dependent cellular cytotoxicity: relevance to global HIV vaccine design

Brief Report: Seminal Plasma Anti-HIV Antibodies Trigger Antibody-dependent Cellular Cytotoxicity: Implications for HIV Transmission

Co-expression of miRNA targeting the expression of PERK, but not PKR, enhances cellular immunity from an HIV-1 Env DNA vaccine

Conjugation of an scFab domain to the oligomeric HIV envelope protein for use in immune targeting

Differentiating founder and chronic HIV envelope sequences.

Disulfide bond that constrains the HIV-1 gp120 V3 domain is cleaved by thioredoxin

Efficient transcription through an intron requires the binding of an Sm-type U1 snRNP with intact stem loop II to the splice donor

Enhancing the antigenicity and immunogenicity of monomeric forms of hepatitis C virus E2 for use as a preventive vaccine

HIV-1 Env- and Vpu-Specific Antibody-Dependent Cellular Cytotoxicity Responses Associated with Elite Control of HIV.

HIV-1-based Virus-like Particles that Morphologically Resemble Mature, Infectious HIV-1 Virions

Hyperimmune bovine colostrum as a low-cost, large-scale source of antibodies with broad neutralizing activity for HIV-1 envelope with potential use in microbicides.

Immune escape from HIV-specific antibody-dependent cellular cytotoxicity (ADCC) pressure

Induction of HIV-1 subtype B and AE-specific neutralizing antibodies in mice and macaques with DNA prime and recombinant gp140 protein boost regimens.

Inhibition of two temporal phases of HIV-1 transfer from primary Langerhans cells to T cells: the role of langerin

Isotype-switched immunoglobulin G antibodies to HIV Gag proteins may provide alternative or additional immune responses to ‘protective’ human leukocyte antigen-B alleles in HIV controllers

Memory B Cells, the HLA-B*57 Allele and Natural Control of HIV Infection

NK cell function and antibodies mediating ADCC in HIV-1-infected viremic and controller patients

Oligomeric structure of the human immunodeficiency virus type 1 envelope protein on the virion surface

Partial efficacy of a broadly neutralizing antibody against cell-associated SHIV infection

Promoting trimerization of soluble human immunodeficiency virus type 1 (HIV-1) Env through the use of HIV-1/simian immunodeficiency virus chimeras

Rapid degranulation of NK cells following activation by HIV-specific antibodies.

Repeated Vaccination of Cows with HIV Env gp140 during Subsequent Pregnancies Elicits and Sustains an Enduring Strong Env-Binding and Neutralising Antibody Response

Role of education and differentiation in determining the potential of natural killer cells to respond to antibody-dependent stimulation.

Sindbis virus vectors elicit hemagglutinin-specific humoral and cellular immune responses and offer a dose-sparing strategy for vaccination

The core domain of hepatitis C virus glycoprotein E2 generates potent cross-neutralizing antibodies in guinea pigs

The maturation of antibody technology for the HIV epidemic

Trimeric gp120-specific bovine monoclonal antibodies require cysteine and aromatic residues in CDRH3 for high affinity binding to HIV Env.

Utility of the Sindbis replicon system as an Env-targeted HIV vaccine.